Systemic Sclerosis-Associated Interstitial Lung Disease: What We Know and How to Incorporate Guidelines into Clinical Practice

Systemic Sclerosis

Efficacy and safety of rituximab versus intravenous cyclophosphamide for systemic sclerosis-associated interstitial lung disease: a retrospective cohort study

Arthritis Res Ther

Hiura R, Ayano M, Uchino A, Hiura J, Ueda N, Tanaka A, Yoshizawa S, Kawano S, Sagawa F, Ota SI, Hirata A, Fujimoto S, Nishimura N, Takaki-Kuwahara A, Kimoto Y, Akashi K, Niiro H

doi: 10.1186/s13075-025-03654-0

Systemic Sclerosis

The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133)

Ann Rheum Dis

Petelytska L, Tofani L, Velauthapillai A, Dobrota R, Becker MO, Mihai C, Muraru S, Elhai M, Jordan S, Hachulla E, Müller-Ladner U, Siegert E, Allanore Y, Riemekasten G, Bergmann C, Becvar R, Solanki K, Anic B, Szabo I, Stamenkovic B, Distler J, Carreira PE, Cuomo G, Castellví I, Balbir-Gurman A, Airò P, Litinsky I, Saketkoo LA, Bertaccini B, Vonk MC, de Vries-Bouwstra J, Hoffmann-Vold AM, Matucci-Cerinic M, Distler O, Bruni C, EUSTAR collaborators

doi: 10.1016/j.ard.2025.12.008

Rheumatoid Arthritis

Progressive interstitial lung disease associated with rheumatoid arthritis and abatacept: data from a multicenter cohort of 526 patients

Rheumatology (Oxford)

Serrano-Combarro A, Atienza-Mateo B, Martín-Gutierrez A, Ibarrola Paino L, Casafont-Solé I, Loarce-Martos J, Blanco-Madrigal JM, Ortega-Castro R, Mena-Vázquez N, Fernández-Díaz C, Loricera J, Ferrer D, Castañeda S, Blanco R, Spanish Collaborative Group of Interstitial Lung Disease Associated with Rheumatoid Arthritis

doi: 10.1093/rheumatology/keag023

Rheumatoid Arthritis

The diagnostic utility of lung ultrasound in the assessment of interstitial lung disease associated with rheumatoid arthritis

Arthritis Res Ther

Zheng S, Zhou Z, Du G, Chen Q, Chen S, Lin J, Hu S, Zhang W, Zheng K, Zhuang J, Huang M, Ruaro B, Bruni C, Hoffmann-Vold AM, Matucci-Cerinic M, Furst DE, Wang Y

doi: 10.1186/s13075-025-03626-4

Systemic Lupus Erythematosus

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Rheumatology (Oxford)

Nakanishi E, Matsushita M, Minowa K, Tada K, Kawamoto T, Kusaoi M, Amano H, Kon T, Morimoto S, Ikeda K, Suzuki S, Nozawa K, Yang KS, Matsudaira R, Katagiri A, Tsushima H, Urasaki W, Nojiri S, Yamaji K, Tamura N

doi: 10.1093/rheumatology/keaf349

Autoimmune Disease

Interstitial Lung Disease in ANCA-Associated Vasculitis: A European Multicentre Study

Arthritis Rheumatol

Chalkia A, Kotnik M, Sadler TJ, Katechis S, Jones R, Kamath A, Mohammad AJ, Monti S, Mukhtyar C, Nanda V, Petrakis I, Petras D, Sinha A, Sivasothy P, Smith R, Stylianou K, Vassilopoulos D, Babar J, Jayne D

doi: 10.1002/art.70078

Systemic Sclerosis

Anti-cytolethal distending toxin antibodies in systemic sclerosis: associations with gastrointestinal disease and immune dysregulation

Rheumatology (Oxford)

Di Ciommo FR, Casciola-Rosen L, Ayla AY, Balar A, Shah AA, Hughes M, Morales W, Pimentel M, Adler BL, McMahan ZH

doi: 10.1093/rheumatology/keaf376

Rheumatoid Arthritis

Risk of total and cause-specific mortality in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis

Rheumatology (Oxford)

Zhang Q, Qi Y, Wang X, McDermott GC, Chang SH, Chaballa M, Khaychuk V, Paudel ML, Sparks JA

doi: 10.1093/rheumatology/keaf380

Rheumatoid Arthritis

Rheumatoid arthritis-associated interstitial lung disease in countries across the world

Semin Arthritis Rheum

Heckert SL, Maarseveen TD, Marges ER, Chopra A, Vega-Morales D, Toit RD, Winchow LL, Govind N, Toro-Gutiérrez CE, Knevel R, van der Helm-van Mil AH, Huizinga TW, Allaart CF, Bergstra SA

doi: 10.1016/j.semarthrit.2025.152719

Related content

Efficacy and safety of rituximab versus intravenous cyclophosphamide for systemic sclerosis-associated interstitial lung disease: a retrospective cohort study

The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133)

Progressive interstitial lung disease associated with rheumatoid arthritis and abatacept: data from a multicenter cohort of 526 patients

The diagnostic utility of lung ultrasound in the assessment of interstitial lung disease associated with rheumatoid arthritis

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Interstitial Lung Disease in ANCA-Associated Vasculitis: A European Multicentre Study

Anti-cytolethal distending toxin antibodies in systemic sclerosis: associations with gastrointestinal disease and immune dysregulation

Risk of total and cause-specific mortality in patients with rheumatoid arthritis-associated interstitial lung disease or bronchiectasis

Rheumatoid arthritis-associated interstitial lung disease in countries across the world